financetom
Business
financetom
/
Business
/
Hershey Posts First-Quarter Beat Amid Price, Volume Gains
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hershey Posts First-Quarter Beat Amid Price, Volume Gains
May 3, 2024 6:20 AM

08:47 AM EDT, 05/03/2024 (MT Newswires) -- Hershey (HSY) on Friday reported better-than-expected first-quarter results buoyed by price hikes and volume gains, while the confectionery company maintained its full-year outlook.

Adjusted earnings came in at $3.07 per share for the March quarter, up from $2.96 the year before and surpassing the Capital IQ-polled consensus of $2.76. Sales advanced 8.9% to $3.26 billion, topping the Street's view for $3.11 billion, as the company benefited from price increases of 5.2% and volume growth of 3.4%.

Hershey shares rose 1.1% in recent premarket activity.

North America confectionery sales climbed 10% to $2.71 billion, driven mainly by accelerated shipments related to the implementation of Hershey's new enterprise resource planning system that was completed in April. North America salty snacks ticked up 1.9% to $275.1 million, boosted by higher prices. International sales rose 1.8% to $270.3 million with growth in Europe and Latin America offset by planned declines in Mexico.

Gross margin expanded by 520 basis points to 51.5% for the quarter driven by price hikes and derivative mark-to-market gains. Selling, marketing and administrative expenses widened to nearly $618 million from $581.6 million year-on-year, according to the company.

"We are off to a strong start and remain on track to deliver our business strategies and financial commitments for the year," Chief Executive Michele Buck said in a statement. "Our investments in innovation, marketing and in-store execution are driving consumer engagement and improving market share performance across segments."

Hershey continues to project adjusted EPS of $9.59 for the 2024 financial year, in line with the Street's current forecast. The company also recorded per-share adjusted EPS of $9.59 last year. Sales are still pegged to grow between 2% and 3% for the current year, while the market is looking for revenue of $11.47 billion.

"As we continue to navigate recent volatility in the business, we remain committed to strategies that drive long-term growth and sustainable value creation," according to Buck.

Price: 198.00, Change: +2.12, Percent Change: +1.08

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
STAAR Surgical Delays Special Shareholder Meeting to Vote on Alcon Merger to Nov. 6
STAAR Surgical Delays Special Shareholder Meeting to Vote on Alcon Merger to Nov. 6
Oct 23, 2025
01:17 PM EDT, 10/23/2025 (MT Newswires) -- STAAR Surgical ( STAA ) said Thursday that it has adjourned its Oct. 23 special stockholders meeting in relation to its merger agreement with Alcon ( ALC ) . The meeting is rescheduled to take place on Nov. 6, STAAR said. The adjournment follows opposition from proxy advisers and major shareholders, including Broadwood...
Scienture Holdings Stock Is Soaring Thursday: What's Fueling The Momentum?
Scienture Holdings Stock Is Soaring Thursday: What's Fueling The Momentum?
Oct 23, 2025
Shares of Scienture Holdings, Inc. ( SCNX ) are rising Thursday after the comprehensive pharmaceutical product company announced the start of commercial sales for Arbli. SCNX shares are powering higher on strong volume. Review the technical setup here. What To Know: Scienture ( SCNX ) said it started commercial sales and fulfillment of the first customer orders for Arbli (losartan potassium) oral...
Sector Update: Health Care
Sector Update: Health Care
Oct 23, 2025
01:15 PM EDT, 10/23/2025 (MT Newswires) -- Health care stocks edged lower Thursday afternoon, with the NYSE Health Care Index easing 0.1% and the Health Care Select Sector SPDR Fund (XLV) fractionally lower. The iShares Biotechnology ETF (IBB) rose 0.2%. In corporate news, Avanos Medical ( AVNS ) shares fell 0.6% after it agreed to sell its US orthopedic rental...
Nebius (NBIS) Stock Is Rebounding Thursday: What's Going On?
Nebius (NBIS) Stock Is Rebounding Thursday: What's Going On?
Oct 23, 2025
Shares of AI infrastructure company Nebius Group NV ( NBIS ) are trading higher Thursday, fueled by strategic news that is overshadowing a recent stock slump. Here’s what investors need to know. NBIS is surging to new heights today. Stay ahead of the curve here. What To Know: On Wednesday, the company announced its autonomous driving subsidiary, Avride, secured up...
Copyright 2023-2026 - www.financetom.com All Rights Reserved